Kibron PLDscreen yields
compound classification by
PLD-index into four risk
categories.
Kibron PLDscreen is based on quantitative surface activity profiling of compounds by the high throughput Kibron Delta-8 analyzer, PLDnanosol reagent, software for data acquisition & analysis, and Kibron microtiter plates.
Basic features and benefits of the Kibron PLDscreen are:
(1) very high, (2) high, (3) medium, and (4) low risk for PLD
Two software options are available: 1) PLDscreen standard software, dedicated only for PLD screening, and 2) PLDscreen PRO software, allowing additionally for physicochemical screening of Kaw, TSA, CMC and surface pKa.
The high throughput, small amount of material and minimal required manual labor allow a truly cost-efficient screening for phospholipidosis.

The Kibron PLDscreen offers high throughput PLD screening with minimal compound consumption, resulting in a fast and cost-efficient, yet highly accurate prediction of PLD.
PLDscreen comprises the Delta-8 high throughput analyzer, PLDnanosol reagent and Kibron microtiter plates.
